Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Publication year range
1.
Rev Gastroenterol Mex ; 82(2): 193-195, 2017.
Article in English, Spanish | MEDLINE | ID: mdl-28268032

ABSTRACT

BACKGROUND: Scleroderma can present with esophageal involvement causing important morbidity. AIMS: To describe the manometric findings and clinical characteristics of patients with scleroderma and esophageal symptoms. MATERIALS AND METHODS: Patients with scleroderma and esophageal symptoms were evaluated through esophageal manometry within the time frame of one year. Descriptive statistics were carried out and the continuous variables were expressed as means and standard deviation. Frequencies were expressed as percentages. RESULTS: The study included 24 female patients with a mean age of 53.5 years and mean disease progression of 7.84 years. The most frequent findings were short and hypotonic lower esophageal sphincter (mean length 1.58cm and mean tone 9.49mmHg) and ineffective esophageal motility (mean non-transmitted waves 92.91%, mean effective primary peristalsis 40.05%, and mean amplitude 13.11mmHg). The most frequent symptom was dysphagia. CONCLUSIONS: Scleroderma is associated with lower esophageal sphincter alterations and symptomatic ineffective esophageal motility.


Subject(s)
Esophageal Motility Disorders/complications , Scleroderma, Systemic/complications , Adolescent , Adult , Aged , Disease Progression , Esophageal Motility Disorders/diagnosis , Esophageal Motility Disorders/physiopathology , Esophageal Sphincter, Lower/physiopathology , Female , Humans , Male , Manometry , Middle Aged , Scleroderma, Systemic/diagnosis , Scleroderma, Systemic/physiopathology , Young Adult
2.
Rev Gastroenterol Mex ; 80(3): 180-5, 2015.
Article in English, Spanish | MEDLINE | ID: mdl-26300323

ABSTRACT

BACKGROUND: The low FODMAP diet eliminates carbohydrates and fermentable alcohols because they are not absorbed by the intestine, but are fermented by the microbiota, causing bloating and flatulence. AIMS: To evaluate the clinical response to the low FODMAP diet in patients with the different clinical subtypes of irritable bowel syndrome (IBS). MATERIALS AND METHODS: Patients attended to at the Gastroenterology Department in 2014 that were diagnosed with IBS based on the Rome III criteria were included in the study. They were managed with a low FODMAP diet for 21 days and their response to the symptoms of abdominal pain, bloating, flatulence, and stool form pre and post-diet were evaluated through the visual analogue scale, Bristol scale, and patient overall satisfaction. The results were analyzed by means, 95% CI, and the Student's t test. RESULTS: Of the 31 patients included in the study, 87% were women and the mean age was 46.48 years. Distribution was: IBS-C 64.5%, IBS-D 22.6%, and IBS-M 12.9%. The score for pain was 6.0 (95% CI 5.04-6.96) and the post-diet score was 2.77 (95% CI 1.60-3.95) (P<.001). The score for bloating was 7.10 (95% CI 6.13-8.06) and the post-diet score was 4.19 (95% CI 2.95-5.44) (P<.001). The score for flatulence was 5.94 (95% CI 4.79-7.08) and the post-diet score was 3.06 (IC95% 1.99-4.14) (P<.001). The pre-diet Bristol Scale result was 3.68 (95% CI 3.14-4.22) and the post-diet result was 4.10 (95% CI 3.66-4.54) (P=.1). The satisfaction percentage was 70.9%. CONCLUSIONS: In this first study on a Mexican population with IBS, there was significant improvement of the main symptoms, including pain, bloating, and flatulence after treatment with a low FODMAP diet.


Subject(s)
Diet, Gluten-Free , Irritable Bowel Syndrome/diet therapy , Adult , Aged , Celiac Disease/diet therapy , Dietary Carbohydrates/adverse effects , Female , Humans , Irritable Bowel Syndrome/complications , Irritable Bowel Syndrome/diagnosis , Longitudinal Studies , Male , Mexico , Middle Aged , Pain/etiology , Patient Satisfaction , Prospective Studies , Treatment Outcome , Young Adult
3.
Brain Res ; 898(2): 342-9, 2001 Apr 20.
Article in English | MEDLINE | ID: mdl-11306021

ABSTRACT

The ventral tegmental area (VTA) has been traditionally related with the control of motor responses. However, some studies show that this area is also involved in the processing of nociceptive information. It has been reported that this nucleus participates in the dissociative analgesia phenomenon. In the few works where electrical stimulation and lesion of the VTA have been performed, evaluated with persistent or chronic pain related behaviors, contradictory results have been obtained. Thus, a more detailed analysis of the role of the VTA in persistent pain is needed. Two series of experiments were performed: lesions of this nucleus were done with radiofrequency, (bilaterally at two points per side using a temperature range from 50 to 80 degrees C), and the VTA was electrically stimulated (10 min daily over 5 days, 2 ms rectangular pulses at 100 Hz during 1 s every 5 s) using two different schemes:10 min before the induction of the nociceptive stimulus and 90 min after the induction of the nociceptive stimulus. The latter allowed us to distinguish if the VTA electrical stimulation had a distinctive antinociceptive effect when applied before or after the induction of the nociceptive stimulus on a persistent pain related behavioral response in the rat, the self injury behavior (SIB). Our results showed that VTA lesions enhanced the occurrence of SIB; while activation of this same nucleus by electrical stimulation after the nociceptive stimulus, but not before, facilitates the analgesic process, expressed as a 1 day delay in SIB onset. These results indicate that the VTA is a brain structure that plays a key role in the processing and modulation of persistent pain information. Data are discussed in terms of the relationship of the VTA with the affective component of pain.


Subject(s)
Analgesia/methods , Behavior, Animal/physiology , Neurons/physiology , Nociceptors/physiology , Pain/physiopathology , Ventral Tegmental Area/physiology , Analgesia/instrumentation , Animals , Carrageenan/pharmacology , Denervation , Electric Stimulation , Inflammation/chemically induced , Inflammation/complications , Inflammation/physiopathology , Male , Neural Pathways/cytology , Neural Pathways/physiology , Neurons/cytology , Nociceptors/cytology , Pain/chemically induced , Rats , Rats, Wistar , Self-Injurious Behavior/chemically induced , Self-Injurious Behavior/physiopathology , Ventral Tegmental Area/cytology , Ventral Tegmental Area/surgery
4.
Infect Immun ; 67(5): 2428-32, 1999 May.
Article in English | MEDLINE | ID: mdl-10225905

ABSTRACT

Nine- to twelve-week-old BALB/c mice were injected in footpads with 10(7) CFU of a Nocardia brasiliensis cell suspension. Typical actinomycetoma lesions, characterized by severe local inflammation with abscess and fistula formation, were fully established by day 28 after infection. These changes presented for 90 days, and then tissue repair with scar formation slowly appeared, with complete healing after 150 days of infection. Some animals developed bone destruction in the affected area. Histopathology showed an intense inflammatory response, with polymorphonuclear cells and hyaloid material around the colonies of the bacteria, some of which were discharged from draining abscesses. Sera from experimental animals were analyzed by Western blotting, and immunodominant antigens P61 and P24 were found as major targets for antibody response. Anti-P24 immunoglobulin M (IgM) isotype antibodies were present as early as 7 days, IgG peaking 45 days after infection. Lymphocyte proliferation with spleen and popliteal lymph node cells demonstrated thymidine incorporation at 7 days after infection, the stimulation index decreasing by day 60. Levels of interleukin-1 (IL-1), IL-2, IL-4, IL-6, tumor necrosis factor alpha, and gamma interferon (IFN-gamma) were determined by enzyme-linked immunosorbent assay in the sera of infected animals. The circulating levels of IFN-gamma increased more than 10 times the basal levels; levels of IL-4, IL-6 and IL-10 also increased during the first 4 days of infection.


Subject(s)
Antigens, Bacterial/administration & dosage , Mycetoma/immunology , Nocardia Infections/immunology , Nocardia/immunology , Animals , Antibodies, Bacterial/blood , Cytokines/blood , Disease Models, Animal , Female , Humans , Immunodominant Epitopes , In Vitro Techniques , Lymphocyte Activation , Male , Mice , Mycetoma/etiology , Mycetoma/pathology , Nocardia/pathogenicity , Nocardia Infections/etiology , Nocardia Infections/pathology , Th1 Cells/immunology , Th2 Cells/immunology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL